Trinity Biotech (TRIB) announced the appointment of Paul Tivnan to its Board of Directors as a Non-Executive Director. Tivnan currently serves as Chief Financial Officer of Deriva Energy
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIB:
- Trinity Biotech Receives Approval for Offshore Manufacturing of HIV Test
- Trinity granted approval for offshore manufacturing of TrinScreen HIV test
- Trinity Biotech Gains Approval for PreClara™ Preeclampsia Testing Service
- Trinity Biotech receives approval from NYSDOH to provide PreClara Ratio
- Trinity Biotech Announces Breakthrough in CGM Technology